Research sheds new light on why pancreatic cancer drugs fail
21 May 2009An international team of scientists, led by researchers based at the Cambridge Research Institute, have discovered a new mechanism that may explain why pancreatic cancer patients are often resistant to a common chemotherapy treatment, germcitabine.